Tag: Servier
“Concern, on the generic front, around the discreet sale of Biogaran by its parent company, Servier”
A box of Ivermectin, a drug manufactured by the Biogaran laboratory, in Paris, April 28, 2020. BENOIT TESSIER / REUTERS Lhe Covid-19 pandemic had revealed one of the great weaknesses…
the Servier group condemned, here is the heavy compensation it will have to pay
This Wednesday, December 20, 2023, the Servier laboratory was sentenced by the Paris Court of Appeal to a heavy fine, as part of the trial linked to the Mediator affair,…
Servier ordered on appeal to reimburse more than 415 million to social security organizations
At the Mediator trial, January 9, 2023. THOMAS SAMSON / AFP This is the conclusion of an appeal trial which lasted six months. The Servier group, which marketed the Mediator,…
Health AI: Servier and Owkin combine data and ML
“AI is (…) at the heart of the medicine of the future with assisted operations, remote patient monitoring, intelligent prostheses, and even personalized treatments thanks to data cross-checking.” This is…
At the end of the Mediator appeal trial, Servier proclaims one last time its “good faith”
At the opening of the Servier laboratories appeal trial, in Paris, on January 9, 2023. THOMAS SAMSON / AFP After five months of hearings, the Mediator’s appeal trial ended on…
For Servier, a new life begins
In order to turn the page on the Mediator, the second French laboratory is betting above all on oncology. One new medicine or one new indication per year. This is…
Oncodesign: Servier exercises an option in Parkinson – 09/27/2022 at 12:21
(CercleFinance.com) – Oncodesign announced on Tuesday that Servier had exercised its exclusive worldwide license option on their joint program in the treatment of Parkinson’s disease. The lifting of this option…
Oncodesign: Servier lifts the exclusive worldwide license option on the program in collaboration with OPM
By Alexandra Saintpierre Published on 09/26/2022 at 7:14 p.m. Photo credit © Reuters …
the lie of Servier recognized, the civil parties divided on the judgment
The pulmonologist Irène Frachon, after the verdict in the Mediator trial, on March 29, at the Paris court. THOMAS COEX / AFP Servier laboratories “Had, from 1995, sufficient elements to…